PortfoliosLab logo
COKE vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between COKE and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

COKE vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Coca-Cola Consolidated, Inc. (COKE) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

COKE:

0.66

ABBV:

0.83

Sortino Ratio

COKE:

1.02

ABBV:

1.21

Omega Ratio

COKE:

1.14

ABBV:

1.19

Calmar Ratio

COKE:

0.98

ABBV:

1.17

Martin Ratio

COKE:

2.58

ABBV:

2.66

Ulcer Index

COKE:

8.01%

ABBV:

9.07%

Daily Std Dev

COKE:

32.64%

ABBV:

28.28%

Max Drawdown

COKE:

-50.93%

ABBV:

-45.09%

Current Drawdown

COKE:

-19.95%

ABBV:

-13.31%

Fundamentals

Market Cap

COKE:

$9.99B

ABBV:

$328.74B

EPS

COKE:

$6.42

ABBV:

$2.34

PE Ratio

COKE:

17.86

ABBV:

79.53

PEG Ratio

COKE:

0.00

ABBV:

0.40

PS Ratio

COKE:

1.45

ABBV:

5.73

PB Ratio

COKE:

6.66

ABBV:

231.51

Total Revenue (TTM)

COKE:

$6.89B

ABBV:

$57.37B

Gross Profit (TTM)

COKE:

$2.74B

ABBV:

$44.44B

EBITDA (TTM)

COKE:

$979.96M

ABBV:

$16.36B

Returns By Period

In the year-to-date period, COKE achieves a -5.55% return, which is significantly lower than ABBV's 6.70% return. Over the past 10 years, COKE has outperformed ABBV with an annualized return of 28.92%, while ABBV has yielded a comparatively lower 15.54% annualized return.


COKE

YTD

-5.55%

1M

0.13%

6M

-8.76%

1Y

21.60%

3Y*

33.75%

5Y*

41.21%

10Y*

28.92%

ABBV

YTD

6.70%

1M

-6.23%

6M

3.65%

1Y

19.62%

3Y*

12.26%

5Y*

19.77%

10Y*

15.54%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Coca-Cola Consolidated, Inc.

AbbVie Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

COKE vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COKE
The Risk-Adjusted Performance Rank of COKE is 7373
Overall Rank
The Sharpe Ratio Rank of COKE is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of COKE is 6666
Sortino Ratio Rank
The Omega Ratio Rank of COKE is 6767
Omega Ratio Rank
The Calmar Ratio Rank of COKE is 8383
Calmar Ratio Rank
The Martin Ratio Rank of COKE is 7676
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 7777
Overall Rank
The Sharpe Ratio Rank of ABBV is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 7070
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 7474
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 8686
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

COKE vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Coca-Cola Consolidated, Inc. (COKE) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current COKE Sharpe Ratio is 0.66, which is comparable to the ABBV Sharpe Ratio of 0.83. The chart below compares the historical Sharpe Ratios of COKE and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

COKE vs. ABBV - Dividend Comparison

COKE's dividend yield for the trailing twelve months is around 4.62%, more than ABBV's 3.43% yield.


TTM20242023202220212020201920182017201620152014
COKE
Coca-Cola Consolidated, Inc.
4.62%1.94%4.90%1.51%0.16%0.38%3.52%4.37%2.56%1.82%1.78%1.14%
ABBV
AbbVie Inc.
3.43%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

COKE vs. ABBV - Drawdown Comparison

The maximum COKE drawdown since its inception was -50.93%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for COKE and ABBV.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

COKE vs. ABBV - Volatility Comparison

Coca-Cola Consolidated, Inc. (COKE) has a higher volatility of 14.88% compared to AbbVie Inc. (ABBV) at 9.85%. This indicates that COKE's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

COKE vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Coca-Cola Consolidated, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20212022202320242025
1.58B
13.34B
(COKE) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

COKE vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Coca-Cola Consolidated, Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
39.7%
83.9%
(COKE) Gross Margin
(ABBV) Gross Margin
COKE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Coca-Cola Consolidated, Inc. reported a gross profit of 627.10M and revenue of 1.58B. Therefore, the gross margin over that period was 39.7%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.

COKE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Coca-Cola Consolidated, Inc. reported an operating income of 189.82M and revenue of 1.58B, resulting in an operating margin of 12.0%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.

COKE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Coca-Cola Consolidated, Inc. reported a net income of 103.61M and revenue of 1.58B, resulting in a net margin of 6.6%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.